Abrogation of the G2 Checkpoint Results in Differential Radiosensitization of G1 Checkpoint-deficient and G1 Checkpoint-competent Cells

KJ Russell, LW Wiens, GW Demers, DA Galloway… - Cancer research, 1995 - AACR
KJ Russell, LW Wiens, GW Demers, DA Galloway, SE Plon, M Groudine
Cancer research, 1995AACR
We have examined the effect of abrogation of the G2 checkpoint on the radiosensitivity of G1
checkpoint-proficient and G1 checkpoint-deficient cells. A549 human lung adenocarcinoma
cells were transduced with the E6 oncogene of the human papillomavirus type 16 to
eliminate their radiation-induced G1 arrest. These E6+ cells exhibited a dose-dependent
increase in radiation resistance compared to control A549 cells transduced with the vector
alone. Treatment (96 h) with 2 mm caffeine resulted in an abrogation of the cellular G2 …
Abstract
We have examined the effect of abrogation of the G2 checkpoint on the radiosensitivity of G1 checkpoint-proficient and G1 checkpoint-deficient cells. A549 human lung adenocarcinoma cells were transduced with the E6 oncogene of the human papillomavirus type 16 to eliminate their radiation-induced G1 arrest. These E6+ cells exhibited a dose-dependent increase in radiation resistance compared to control A549 cells transduced with the vector alone. Treatment (96 h) with 2 mm caffeine resulted in an abrogation of the cellular G2 checkpoint in both E6+ and control cells and a differential radiosensitizing effect on the two cell lines such that the E6+ clones and the vector controls became equally radiosensitive. These data show that human tumors which are radioresistant due to the loss of the p53-mediated G1 checkpoint can be made radiosensitive by abrogation of the G2 checkpoint. The implications of these results for cancer therapy are discussed.
AACR